A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia.

Buchanan, Robert W

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. [electronic resource] - Biological psychiatry Mar 2011 - 442-9 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

1873-2402

10.1016/j.biopsych.2010.09.052 doi


Adolescent
Adult
Cognition--drug effects
Cognition Disorders--drug therapy
Diagnostic and Statistical Manual of Mental Disorders
Double-Blind Method
Female
GABA Agonists--adverse effects
Humans
Male
Middle Aged
Neuropsychological Tests
Psychiatric Status Rating Scales
Pyridazines--therapeutic use
Receptors, GABA-A--drug effects
Schizophrenia--drug therapy
Schizophrenic Psychology
Treatment Outcome
Triazoles--therapeutic use
Young Adult